Used as an intermediate in the synthesis of pharmaceuticals, particularly in the development of protease inhibitors and other bioactive molecules. Its structure supports peptide mimetic design, enabling enhanced metabolic stability and bioavailability in drug candidates. Commonly employed in solid-phase peptide synthesis and medicinal chemistry research due to its protective group properties, especially for amine functionalities. Also utilized in the preparation of kinase inhibitors and antiviral agents.